Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Revista
Tipo del documento
Intervalo de año de publicación
1.
SADJ ; 65(9): 410, 412-4, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21180287

RESUMEN

INTRODUCTION: Patients receiving radiation therapy due to oral cancer develop complications such as hyposalivation, mucositis, oral infections, dental hypersensitivity and caries. Mouthrinses can alleviate some of these problems. AIMS AND OBJECTIVES: To investigate the in vitro antimicrobial properties and cytotoxicity of an experimental mouthrinse. METHODS: The mouthrinse contained 30% hexylene glycol (glycerine), 7% potassium nitrate and 0.025% sodium fluoride. The minimal inhibitory concentration (MIC) of these ingredients and the mixture was determined for C. albicans, S. aureus and S. mutans over 24 hours at different concentrations. The MICs of two commercial mouthrinses, Corsodyl and Plax, were also determined using the same organisms. All mouthrinses were then tested to determine the percentage kill over 1, 2, and 3 minutes. RESULTS: The MICs for hexylene glycol were 10%, 30% and 10% for C. albicans, S. aureus and S. mutons respectively. Potassium nitrate and sodium fluoride had no antimicrobial effects. The MIC of Corsodyl was 0.016 mg/ml for all the test organisms. The MIC for Plax varied from 0.0002 mg/ml to 0.001 mg/ml. The kill rates for all mouthrinses were acceptable, with no statistical differences between them. The experimental mouthrinse was not toxic to human oesophageal SCC cells after 1 minute exposure. At the time of the experiment, the costs of a similar quantity of the experimental mouthrinse, Corsodyl and Plax were R5.24, R30.00 and R10.00 respectively. CONCLUSIONS: The experimental mouthrinse was cost-effective and proved to have an antimicrobial effect and could be used safely to alleviate oral infections, desensitize teeth, improve oral hygiene and control dental caries in cancer patients after radiation therapy.


Asunto(s)
Antiinfecciosos Locales/farmacología , Antisépticos Bucales/farmacología , Radioterapia , Antiinfecciosos Locales/economía , Antiinfecciosos Locales/toxicidad , Benzoatos/farmacología , Candida albicans/efectos de los fármacos , Carcinoma de Células Escamosas/patología , Cariostáticos/farmacología , Cariostáticos/toxicidad , Adhesión Celular/efectos de los fármacos , Línea Celular Tumoral , Clorhexidina/análogos & derivados , Clorhexidina/farmacología , Desensibilizantes Dentinarios/farmacología , Desensibilizantes Dentinarios/toxicidad , Relación Dosis-Respuesta a Droga , Neoplasias Esofágicas/patología , Glicoles/farmacología , Glicoles/toxicidad , Humanos , Lubricantes/farmacología , Lubricantes/toxicidad , Ensayo de Materiales , Pruebas de Sensibilidad Microbiana , Antisépticos Bucales/economía , Antisépticos Bucales/toxicidad , Nitratos/farmacología , Nitratos/toxicidad , Compuestos de Potasio/farmacología , Compuestos de Potasio/toxicidad , Radioterapia/efectos adversos , Dodecil Sulfato de Sodio/farmacología , Fluoruro de Sodio/farmacología , Fluoruro de Sodio/toxicidad , Staphylococcus aureus/efectos de los fármacos , Streptococcus mutans/efectos de los fármacos , Factores de Tiempo , Triclosán/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA